Page 17 - Human Data Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IQVIA report forecasts global medicine spending to hit $1.6 trillion in 2025 30th April 2021 A new report looking at global medicine spending and usage trends has forecasted growth for the global medicine market through 2025, noting a ‘modest’ impact on pre-pandemic drivers of medicine use and spending from COVID-19. The report, released by the IQVIA Institute for Human Data Science, has projected global spending on medicines to grow at 3-6% CAGR through 2025, reaching approximately $1.6 trillion by 2025, excluding spending on COVID-19 vaccines. The increase in global medicine spending is...

Ninian Reid / Flickr cc While Europe reports its first significant decline in COVID-19 cases in 2 months, infections in India continue to rage as the world's case total approaches 150 million. More resources to India India's COVID-19 surge continues unabated, with 386,829 new cases and 3,501 deaths, according to World O Meter. The daily case number is the highest any country has ever recorded, and it marks the ninth day in a row the country has reported more than 300,000. The crisis has galvanized organizations and government bodies into action: The World Health Organization (WHO) alone is se...

FDA has not approved any biosimilars in 2021 after only approving three in 2020. EMA approves second Novolog® (insulin aspartate), fifth Avastin® (bevacizumab), eighth Neulasta® (pegfilgrastim), and twelfth Humira® (adalimumab) biosimilars, and withdraws approval of an adalimumab biosimilar and a pegfilgrastim biosimilar. Given the increasing number of approved biosimilars in Europe, biosimilar manufacturers are increasingly deciding to not market their products due to commercial reasons. As pharmaceutical drug costs attract increasing media attention and political scrutiny, a growing num...

PHOENIX – Cancer screenings in the U.S. have plunged since the start of the pandemic almost a year ago, prompting health advocates to increase calls for the public to stop postponing these potentially life-saving procedures. More than one-third of adults have failed to receive recommended cancer screenings during the pandemic, according to “Cancer Won’t Wait and Neither Should You,” a bulletin published by the American Cancer Society and the National Comprehensive Cancer Network. Fear of getting COVID-19 at screening centers and job losses that have affected insuranc...

Feb. 22, 2021 Experts say more than a third of adults have not received recommended cancer screenings during the pandemic – in part due to fear of contracting COVID-19. That worries advocates, who now are urging Americans to get these potentially life-saving procedures. (Photo by Specialist 2nd Class Joseph Moon/U.S. Navy) PHOENIX – Cancer screenings in the U.S. have plunged since the start of the pandemic almost a year ago, prompting health advocates to increase calls for the public to stop postponing these potentially life-saving procedures. More than one-third of adults have failed t...